U.S. stocks gave up early gains and were little changed in light trading on Thursday as a weakness in financial stocks offset gains in healthcare companies.
The Dow Jones Industrial Average was down 0.18 percent at 19,798.92, the S&P 500 was down 0.16 percent at 2,246.21 and the Nasdaq Composite was down 0.32 percent at 5,421.294.
** NVIDIA CORP, $106.03, -2.95 pct
** ADVANCED MICRO DEVICES INC, $11.325, -1.95 pct
Nvidia’s stock was on track for the second straight day of losses after short seller Citron Research tweeted that the chipmaker’s shares would slip to $90 in 2017.
Rival Advanced Micro Devices also fell on the news.
** GOLDCORP INC, $13.73, +4.33 pct
** NEWMONT MINING CORP, $34.59, +5.52 pct
** ALAMOS GOLD INC, $7.27, +10.82 pct
** IAMGOLD CORP, $3.9, +6.56 pct
** YAMANA GOLD INC, $2.96, +8.03 pct
** AGNICO EAGLE MINES LTD, $42.74, +5.53 pct
** HARMONY GOLD MINING COMPANY LTD, $2.315, +6.19 pct
** GOLD FIELDS LTD, $3.16, +5.33 pct
Gold prices rose to their highest in two weeks on Thursday, helped by a decline in dollar and U.S. bond yields following weaker-than-expected economic data.
** CEMPRA INC, $2.675, -56.15 pct
The drug developer said the U.S. FDA rejected its antibiotic to treat pneumonia, citing inadequate data on the drug’s impact on the liver and unresolved manufacturing issues.
** SEARS HOLDINGS CORP, $8.335, +1.89 pct
The company said it obtained a secured standby letter of credit facility of up to $200 million from ESL Investments Inc, the hedge fund headed by Sears CEO Edward Lampert, that would help the company with additional liquidity to fund its operations.
** FORTRESS BIOTECH INC, $2.78, +21.40 pct
The drug developer said a case study from an early-stage trial of its treatment for glioblastoma, a type of brain tumor, would be published in a medical journal on Thursday.
** PRIMA BIOMED LTD, $2.49, +6.99 pct
The Australian biotechnology company said interim data from trial showed its drug, IMP321, in combination with PD-1 blocking antibody, is safe to treat patients with metastatic melanoma, a type of skin cancer.
** INTERPACE DIAGNOSTICS GROUP INC, $5.8632, -21.82 pct
The molecular diagnostic test and pathology service provider implemented 1-for-10 reverse stock split, bringing its outstanding shares down to 2 million from 20.2 million. (Compiled by Komal Khettry in Bengaluru; Editing by Anil D’Silva)